{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:40:53Z","timestamp":1781134853237,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1053\/j.semperi.2019.01.003","type":"journal-article","created":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T17:36:25Z","timestamp":1548092185000},"page":"141-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Pharmacological treatment of opioid use disorder in pregnancy"],"prefix":"10.1053","volume":"43","author":[{"given":"Christina E.","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaylin A.","family":"Klie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semperi.2019.01.003_bib0001","series-title":"Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs","first-page":"211","article-title":"Medication \u2013assisted treatment for opioid addiction during pregnancy","year":"2005"},{"key":"10.1053\/j.semperi.2019.01.003_bib0002","series-title":"A Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorders","year":"2016"},{"key":"10.1053\/j.semperi.2019.01.003_bib0003","series-title":"Principles of Addiction Medicine","first-page":"120","article-title":"The pharmacology of long-acting as contrasted with short-acting opioids","author":"Ries","year":"2009"},{"issue":"12","key":"10.1053\/j.semperi.2019.01.003_bib0004","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1111\/add.12682","article-title":"The impact of methadone maintenance therapy on hepatitis c incidence among illicit drug users","volume":"109","author":"Nolan","year":"2012","journal-title":"Addiction"},{"issue":"9991","key":"10.1053\/j.semperi.2019.01.003_bib0005","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(14)62338-2","article-title":"Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomized, open-label trial","volume":"386","author":"Rich","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.semperi.2019.01.003_bib0006","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1360-0443.2007.02090.x","article-title":"Exposure to methadone maintenance treatment reduces long-term mortality","volume":"103","author":"Gibson","year":"2008","journal-title":"Addiction"},{"issue":"5","key":"10.1053\/j.semperi.2019.01.003_bib0007","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2105\/AJPH.2012.301049","article-title":"Opioid agonist treatments and heroin overdose deaths in Baltimore, Marylang 1995-2009","volume":"103","author":"Schwartz","year":"2013","journal-title":"Am J Public Health"},{"key":"10.1053\/j.semperi.2019.01.003_bib0008","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jsat.2007.10.007","article-title":"Treatment of opioid-dependence pregnant women: clinical and research issues","volume":"35","author":"Jones","year":"2008","journal-title":"J Subst Abuse Treat"},{"key":"10.1053\/j.semperi.2019.01.003_bib0009","unstructured":"Federal Regulation of Methadone Treatment, Institute of Medicine (US) Committee on Federal Regulation of Methadone Treatment; Rettig RA, Yarmolinsky A, editors. Washington (DC): National Academies Press (US); 1995."},{"key":"10.1053\/j.semperi.2019.01.003_bib0010","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJMra1604339","article-title":"Treatment of opioid-use disorders","volume":"375","author":"Schuckit","year":"2016","journal-title":"New Eng J Med"},{"key":"10.1053\/j.semperi.2019.01.003_bib0011","series-title":"Basic & Clinical Pharmacology","author":"Katzung","year":"2018"},{"key":"10.1053\/j.semperi.2019.01.003_bib0012","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ogc.2014.02.005","article-title":"Buprenorphine and methadone for opioid addiction during pregnancy","volume":"41","author":"Mozurewich","year":"2014","journal-title":"Obstet Gynecol Clin N Am"},{"key":"10.1053\/j.semperi.2019.01.003_bib0013","series-title":"The ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use","year":"2015"},{"issue":"4","key":"10.1053\/j.semperi.2019.01.003_bib0014","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jsat.2011.05.002","article-title":"Changes in methadone maintenance therapy during and after pregnancy","volume":"41","author":"Albright","year":"2011","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"10.1053\/j.semperi.2019.01.003_bib0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/14767050802452291","article-title":"Maternal methadone dosing schedule and fetal neurobehaviour","volume":"22","author":"Jansson","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1053\/j.semperi.2019.01.003_bib0016","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.amjcard.2013.05.037","article-title":"QTc interval screening in an opioid treatment program","volume":"112","author":"Katz","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semperi.2019.01.003_bib0017","doi-asserted-by":"crossref","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews 2009, Issue 3. Art.No.: CD002209.","DOI":"10.1002\/14651858.CD002209.pub2"},{"key":"10.1053\/j.semperi.2019.01.003_bib0018","doi-asserted-by":"crossref","unstructured":"Burns L, Mattick RP, Lim K, Wallace C. Methadone in pregnancy: treatment retention and neonatal outcomes. Addiction. 102;264-270.","DOI":"10.1111\/j.1360-0443.2006.01651.x"},{"issue":"4","key":"10.1053\/j.semperi.2019.01.003_bib0019","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ajog.2011.04.001","article-title":"Management of women treated with buprenorphine during pregnancy","volume":"205","author":"Alto","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2019.01.003_bib0020","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"American Society of Addiction Medicine. ACOG Committee Opinion No. 711: opioid use and opioid use disorder in pregnancy","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semperi.2019.01.003_bib0021","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0376-8716(03)00062-0","article-title":"Use of buprenorphine in pregnancy: patient management and effects on the neonate","volume":"70","author":"Johnson","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1053\/j.semperi.2019.01.003_bib0022","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1053\/j.semperi.2019.01.003_bib0023","article-title":"Maintenance agonist treatments for opiate-dependent pregnant women","author":"Minozzi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2019.01.003_bib0024","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semperi.2019.01.003_bib0025","doi-asserted-by":"crossref","unstructured":"Zedler BK, Mann AL, Kim MM, et al. Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child. Addiction. 111;2115-2128.","DOI":"10.1111\/add.13462"},{"key":"10.1053\/j.semperi.2019.01.003_bib0026","series-title":"ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use","year":"2015"},{"key":"10.1053\/j.semperi.2019.01.003_bib0027","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1360-0443.2012.03811.x","article-title":"Naltrexone in the treatment of opioid-dependence pregnant women: the case for a considered and measured approach to research","volume":"108","author":"Jones","year":"2013","journal-title":"Addiction"},{"issue":"1","key":"10.1053\/j.semperi.2019.01.003_bib0028","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0091-3057(97)00419-X","article-title":"Opioid receptor blockade throughout prenatal life confers long-term insensitivity to morphine and alters mu opioid receptors","volume":"59","author":"Zagon","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"issue":"9.2","key":"10.1053\/j.semperi.2019.01.003_bib0029","first-page":"7","article-title":"Reproductive toxicity and teratology evaluations of naltrexone","volume":"45","author":"Christian","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"10.1053\/j.semperi.2019.01.003_bib0030","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1479-828X.2001.tb01322.x","article-title":"Obstetric and neonatal outcomes associated with maternal naltrexone exposure","volume":"41","author":"Hulse","year":"2001","journal-title":"Aust NZ Obstet Gynaecol"},{"key":"10.1053\/j.semperi.2019.01.003_bib0031","first-page":"93","article-title":"A possible role for implanatable naltrexone in the management of the high-risk pregnant heroin user","volume":"42","author":"Hulse","year":"2002","journal-title":"Aust NA J Obstet Gynaecol"},{"key":"10.1053\/j.semperi.2019.01.003_bib0032","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.0004-8666.2002.548_14.x","article-title":"Using naltrexone implants in the management of the pregnant heroin user","volume":"42","author":"Hulse","year":"2002","journal-title":"Aust NZ Obstet Gynaecol"},{"key":"10.1053\/j.semperi.2019.01.003_bib0033","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2147\/TCRM.S141332","article-title":"The challenge of perioperative pain management in opioid-tolerant patients","volume":"13","author":"Coluzzi","year":"2017","journal-title":"Ther Clin Risk Manage"},{"issue":"3","key":"10.1053\/j.semperi.2019.01.003_bib0034","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0890334404266881","article-title":"Transfer of naltrexone and its metabolite 6,B-naltrexol into human milk","volume":"20","author":"Chan","year":"2004","journal-title":"J Hum Lact"},{"key":"10.1053\/j.semperi.2019.01.003_bib0036","series-title":"Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants","year":"2018"},{"key":"10.1053\/j.semperi.2019.01.003_bib0037","series-title":"Committee Opinion N. 711","first-page":"e81","volume":"130","year":"2017"},{"key":"10.1053\/j.semperi.2019.01.003_bib0038","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/0002-9378(73)90953-8","article-title":"Narcotic withdrawal in pregnancy: still birth incidence with a case report","volume":"116","author":"Rementeria","year":"1973","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2019.01.003_bib0039","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9378(75)90613-4","article-title":"Fetal stress from methadone withdrawal","volume":"122","author":"Zuspan","year":"1975","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2019.01.003_bib0040","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ajog.2016.03.015","article-title":"Detoxification from opiate drugs during pregnancy","volume":"215","author":"Bell","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2019.01.003_bib0041","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajog.2013.05.026","article-title":"The obstetrical and neonatal impact of maternal opioid detoxification in pregnancy","volume":"209","author":"Stewart","year":"2013","journal-title":"Am J Obstet Gynecol"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000519300035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000519300035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:53:46Z","timestamp":1758938026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000519300035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0146000519300035"],"URL":"https:\/\/doi.org\/10.1053\/j.semperi.2019.01.003","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological treatment of opioid use disorder in pregnancy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semperi.2019.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}